Translational Protein Biomarker Workshop, co-organized by NMI, the GBM Bioanalytics Study Group, and SIGNATOPE GmbH
The NMI is hosting a Protein Biomarker Workshop together with the GBM Bioanalytics Study Group and SIGNATOPE.
The event brings together leading international scientists from academic research, the pharmaceutical industry, and clinical practice. The focus is on current developments in protein biomarker research, particularly innovative technologies such as ultrasensitive immunoassays, multiplex affinity platforms, and mass spectrometric methods for quantitative protein analysis.
In addition to technological aspects, the conference will also address regulatory requirements and strategies for the successful translation of biomarkers into clinical trials. Application examples range from drug-induced organ damage and therapy monitoring to concepts in personalized medicine.
Presentations by:
Dr. Christoph Borchers (Jewish General Hospital, Montreal)
Warren Glaab (Merck Sharp & Dohme, USA)
Prof. Dr. Chris Goldring (University of Liverpool, UK)
Dr. med. Klemens Ruprecht (Universität Heidelberg)
Dr. Ulrich Kunz (Boehringer Ingelheim)
Dr. Dr. med. Susanne Roth (Universitätsklinikum Tübingen)
Prof. Dr. Jochen Schwenk (KTH Royal Institute of Technology, Stockholm)
Dr. Marcus Bantscheff (Roche, Basel)a
